Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MRK
|
Bruce N Kuhlik
Exe V-P & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 11,708 Added 6.96% |
-
|
May 02
2015 |
MRK
|
Adele D Ambrose
Sr.V-P & Chief Comuns Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,423 Reduced 6.84% |
$85,181
$59.86 p/Share
|
May 02
2015 |
MRK
|
Adele D Ambrose
Sr.V-P & Chief Comuns Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,818 Added 15.51% |
-
|
May 02
2015 |
MRK
|
Willie A Deese
Exe V-P & Pres. MMD |
SELL
Payment of exercise price or tax liability
|
Direct | 3,438 Reduced 2.8% |
$205,799
$59.86 p/Share
|
May 02
2015 |
MRK
|
Willie A Deese
Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct | 7,636 Added 5.86% |
-
|
May 02
2015 |
MRK
|
Richard R. De Luca
EVP&Pres, Merck Animal Heallth |
SELL
Payment of exercise price or tax liability
|
Direct | 2,640 Reduced 18.13% |
$158,030
$59.86 p/Share
|
May 02
2015 |
MRK
|
Richard R. De Luca
EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct | 5,090 Added 25.9% |
-
|
May 02
2015 |
MRK
|
Julie L. Gerberding
EVP, Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,818 Added 13.09% |
-
|
May 02
2015 |
MRK
|
Julie L. Gerberding
EVP, Chief Patient Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,214 Reduced 4.79% |
$72,670
$59.86 p/Share
|
May 02
2015 |
MRK
|
Clark Golestani
EVP & Chief Info Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,291 Added 18.25% |
-
|
May 02
2015 |
MRK
|
Clark Golestani
EVP & Chief Info Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 854 Reduced 8.32% |
$51,120
$59.86 p/Share
|
May 02
2015 |
MRK
|
Weir Mirian M Graddick
Exe V-P, HR |
BUY
Exercise of conversion of derivative security
|
Direct | 8,654 Added 6.92% |
-
|
May 02
2015 |
MRK
|
Weir Mirian M Graddick
Exe V-P, HR |
SELL
Payment of exercise price or tax liability
|
Direct | 4,488 Reduced 3.86% |
$268,652
$59.86 p/Share
|
May 02
2015 |
MRK
|
Rita A Karachun
Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 1,755 Reduced 11.6% |
$105,054
$59.86 p/Share
|
May 02
2015 |
MRK
|
Rita A Karachun
Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 4,709 Added 23.74% |
-
|
May 02
2015 |
MRK
|
Michael Rosenblatt
Exec V-P & Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,980 Reduced 5.73% |
$118,523
$59.86 p/Share
|
May 02
2015 |
MRK
|
Michael Rosenblatt
Exec V-P & Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,818 Added 9.96% |
-
|
May 02
2015 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
SELL
Payment of exercise price or tax liability
|
Direct | 8,709 Reduced 45.02% |
$521,321
$59.86 p/Share
|
May 02
2015 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct | 19,343 Added 50.0% |
-
|
May 02
2015 |
ACU
|
Brian S Olschan
President and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 49 Added 0.12% |
$479
$9.77 p/Share
|
May 01
2015 |
ACU
|
Brian S Olschan
President and COO |
SELL
Open market or private sale
|
Direct | 49 Reduced 0.12% |
$909
$18.55 p/Share
|
May 01
2015 |
LOW
|
Ricky D Damron
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 11,925 Reduced 11.31% |
$843,097
$70.7 p/Share
|
May 01
2015 |
AAPL
|
Angela J Ahrendts
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 159,549 Added 42.59% |
-
|
May 01
2015 |
AAPL
|
Angela J Ahrendts
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 82,141 Reduced 38.19% |
$10,592,082
$128.95 p/Share
|
May 01
2015 |
TSLA
|
Kimbal Musk
Director |
SELL
Open market or private sale
|
Direct | 6,401 Reduced 4.03% |
$1,431,136
$223.58 p/Share
|
May 01
2015 |
TSLA
|
Kimbal Musk
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 6,401 Added 3.88% |
$122,899
$19.2 p/Share
|
May 01
2015 |
FHN
|
Robert B Carter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 8.58% |
-
|
May 01
2015 |
FHN
|
John C Compton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 6.84% |
-
|
May 01
2015 |
FHN
|
Mark A Emkes
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 10.49% |
-
|
May 01
2015 |
FHN
|
Corydon J Gilchrist
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 7.35% |
-
|
May 01
2015 |
FHN
|
Vicky B Gregg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 15.94% |
-
|
May 01
2015 |
FHN
|
R Brad Martin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 0.96% |
-
|
May 01
2015 |
FHN
|
Scott M Niswonger
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 0.86% |
-
|
May 01
2015 |
FHN
|
Vicki R Palmer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 12.27% |
-
|
May 01
2015 |
FHN
|
Colin V Reed
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 4.79% |
-
|
May 01
2015 |
FHN
|
Cecelia D. Stewart
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 30.35% |
-
|
May 01
2015 |
FHN
|
Luke Yancy Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,548 Added 11.79% |
-
|
May 01
2015 |
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 86,598 Added 33.09% |
$725,691
$8.38 p/Share
|
May 01
2015 |
R
|
John M Berra
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 4.36% |
-
|
May 01
2015 |
R
|
Robert J. Eck
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 10.33% |
-
|
May 01
2015 |
R
|
Robert Hagemann
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 19.24% |
-
|
May 01
2015 |
R
|
L Patrick Hassey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 5.48% |
-
|
May 01
2015 |
R
|
Michael F Hilton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 16.08% |
-
|
May 01
2015 |
R
|
Tamara L. Lundgren
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 18.23% |
-
|
May 01
2015 |
R
|
Luis P Nieto Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 5.99% |
-
|
May 01
2015 |
R
|
Abbie J Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 4.29% |
-
|
May 01
2015 |
R
|
E Follin Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 5.06% |
-
|
May 01
2015 |
R
|
Hansel E Tookes Ii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,137 Added 4.15% |
-
|
May 01
2015 |
NEM
|
Stephen P Gottesfeld
EVP and Chief S&EA Officer |
SELL
Open market or private sale
|
Direct | 94 Reduced 0.12% |
$2,448
$26.04 p/Share
|
May 01
2015 |
NEM
|
Thomas P Mahoney
Vice President and Treasurer |
SELL
Open market or private sale
|
Direct | 692 Reduced 0.86% |
$18,027
$26.05 p/Share
|
May 01
2015 |